Valuation Amplifon CINNOBER BOAT
Stocks
0N61
IT0004056880
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | - |
| 06-09 | Buy-side pressure on MIB; Unipol and BPER lead gains | AN |
| 06-08 | Clínica Baviera, the copy-paste machine |  |
Company Valuation: Amplifon
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 10,667 | 6,249 | 7,068 | 5,604 | 3,024 | 2,825 | - | - |
| Change | - | -41.42% | 13.1% | -20.71% | -46.03% | -6.59% | - | - |
| Enterprise Value (EV) 1 | 11,539 | 7,581 | 8,399 | 7,059 | 4,545 | 4,505 | 3,924 | 3,854 |
| Change | - | -34.3% | 10.79% | -15.95% | -35.62% | -0.89% | -12.88% | -1.8% |
| P/E Ratio | 67.6x | 34.9x | 45.2x | 38.6x | 33.5x | 22.6x | 14.7x | 12.6x |
| PBR | 11.5x | 6.02x | 6.43x | 4.87x | 3.03x | 1.91x | 1.99x | 1.81x |
| PEG | - | 2.6x | -3.5x | -5.46x | -0.9x | 1.5x | 0.3x | 0.7x |
| Capitalization / Revenue | 5.48x | 2.95x | 3.13x | 2.33x | 1.26x | 1.17x | 1.1x | 1.04x |
| EV / Revenue | 5.92x | 3.58x | 3.72x | 2.93x | 1.9x | 1.86x | 1.52x | 1.41x |
| EV / EBITDA | 23.9x | 14.4x | 15.5x | 12.4x | 8.41x | 7.88x | 6.26x | 5.71x |
| EV / EBIT | 44x | 26.6x | 30.7x | 26.6x | 16.2x | 15.5x | 11.2x | 9.89x |
| EV / FCF | 45.3x | 30.7x | 30.4x | 23.2x | 15.3x | 17.6x | 13.3x | 12.3x |
| FCF Yield | 2.21% | 3.25% | 3.29% | 4.32% | 6.54% | 5.7% | 7.52% | 8.15% |
| Dividend per Share 2 | 0.26 | 0.29 | 0.29 | 0.29 | 0.29 | 0.2518 | 0.3064 | 0.3323 |
| Rate of return | 0.55% | 1.04% | 0.93% | 1.17% | 2.11% | 2.36% | 2.88% | 3.12% |
| EPS 2 | 0.702 | 0.796 | 0.693 | 0.644 | 0.41 | 0.4709 | 0.7234 | 0.8455 |
| Distribution rate | 37% | 36.4% | 41.8% | 45% | 70.7% | 53.5% | 42.4% | 39.3% |
| Net sales 1 | 1,948 | 2,119 | 2,260 | 2,409 | 2,396 | 2,424 | 2,576 | 2,724 |
| EBITDA 1 | 482.8 | 525.3 | 541.6 | 567.7 | 540.4 | 571.5 | 626.7 | 674.4 |
| EBIT 1 | 262.1 | 285.3 | 274 | 265 | 281.3 | 289.7 | 349.2 | 389.6 |
| Net income 1 | 157.8 | 178.5 | 155.1 | 145.4 | 91.3 | 133.7 | 179.7 | 206.6 |
| Net Debt 1 | 871.2 | 1,332 | 1,331 | 1,455 | 1,521 | 1,680 | 1,099 | 1,029 |
| Reference price 2 | 47.45 | 27.82 | 31.34 | 24.85 | 13.75 | 10.65 | 10.65 | 10.65 |
| Nbr of stocks (in thousands) | 224,815 | 224,622 | 225,517 | 225,501 | 219,937 | 265,245 | - | - |
| Announcement Date | 3/3/22 | 3/1/23 | 3/7/24 | 3/6/25 | 3/4/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E Ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 22.18x | 3.29x | 12.35x | 2.89% | 154B | |
| 20.16x | 3.48x | 12.52x | 3.56% | 103B | |
| 36x | 8.9x | 23.96x | 1.07% | 55.22B | |
| 14.84x | 0.18x | 11.13x | 0.84% | 54.8B | |
| 36.44x | 2.93x | 10.05x | 2.63% | 40.3B | |
| 35.05x | 1.3x | 11.46x | 0.22% | 30.96B | |
| 30.79x | 5.5x | 17.54x | -.--% | 29.08B | |
| 39.05x | 6.75x | 24.36x | 0.27% | 23.23B | |
| 23.72x | 3.03x | 12.36x | 1.36% | 20.25B | |
| Average | 28.69x | 3.93x | 15.08x | 1.43% | 56.71B | |
| Weighted average by Cap. | 25.70x | 3.72x | 14.11x | 2.08% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- AMP Stock
- 0N61 Stock
- Valuation Amplifon
Select your edition
All financial news and data tailored to specific country editions
